Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin (Diphereline) vs hCG for ovulation triggering in infertile women with polycystic ovarian syndrome
IRCT20200122046221N3Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in female infertility and polycystic ovary syndrome (PCOS) comparing Triptorelin (Diphereline) ovulation trigger with hCG ovulation trigger (2 arms). Started Feb 2022; status: completed.
02
Drugs
triptorelinhuman chorionic gonadotropin
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20200122046221N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200122046221N3.